The role of induction therapy and surgery for stage IIIA lung cancerGINSBERG, R. J.Annals of oncology. 1995, Vol 6, pp 29-32, issn 0923-7534, SUP3Conference Paper

Performance status rather than age is the key prognostic factor in second-line treatment of elderly patients with epithelial ovarian carcinomaGRONLUND, Bo; HOGDALL, Claus; HANSEN, Heine H et al.Cancer. 2002, Vol 94, Num 7, pp 1961-1967, issn 0008-543XArticle

Issues at the cutting edge in stage III non-small-cell lung cancerGREEN, M. R; LILENBAUM, R. C.Annals of oncology. 1995, Vol 6, pp 33-36, issn 0923-7534, SUP3Conference Paper

Third IASLC [International Association for the Study of Lung Cancer] workshop on small cell lung cancer: Elsinore, Denmark, 18-22 June 1989HANSEN, HEINE H; KRISTJANSEN, PAUL E. G.Lung cancer. 1989, Vol 5, Num 4-6, issn 0169-5002, 213 p.Conference Proceedings

Results of reinduction therapy with paclitaxel and carboplatin in recurrent epithelial ovarian cancerGRONLUND, Bo; HØGDALL, Claus; HANSEN, Heine H et al.Gynecologic oncology (Print). 2001, Vol 83, Num 1, pp 128-134, issn 0090-8258Conference Paper

Dealing with initial chemotherapy doses : a new basis for treatment optimisation in limited small-cell lung cancerLE CESNE, A; LE CHEVALIER, T; ARRIAGADA, R et al.Annals of oncology. 1995, Vol 6, pp 53-56, issn 0923-7534, SUP3Conference Paper

Diagnosis and staging of bronchogenic carcinoma by transtracheal and transbronchial needle aspirationCASTELLA, J; BUJ, J; PUZO, C et al.Annals of oncology. 1995, Vol 6, pp 21-24, issn 0923-7534, SUP3Conference Paper

Pulmonary neuroendocrine tumors: Incidence and prognosis of histological subtypes. A population-based study in DenmarkSKULADOTTIR, Halla; HIRSCH, Fred R; HANSEN, Heine H et al.Lung cancer. 2002, Vol 37, Num 2, pp 127-135, issn 0169-5002Article

Molecular genetic tumor markers in the early diagnosis and screening of non-small-cell lung cancerJACOBSON, D. R; FISHMAN, C. L; MILLS, N. E et al.Annals of oncology. 1995, Vol 6, pp 3-8, issn 0923-7534, SUP3Conference Paper

Single agent Taxol, 3-hour infusion, in untreated advanced non-small-cell lung cancerALBEROLA, V; ROSELL, R; GONZALEZ-LARRIBA, J. L et al.Annals of oncology. 1995, Vol 6, pp 49-52, issn 0923-7534, SUP3Conference Paper

PET/CT imaging in response evaluation of patients with small cell lung cancerFISCHER, Barbara M; MORTENSEN, Jann; LANGER, Seppo W et al.Lung cancer. 2006, Vol 54, Num 1, pp 41-49, issn 0169-5002, 9 p.Article

p53 nuclear immunostaining and gene mutations in non-small-cell lung cancer and their effects on patient survivalMITSUDOMI, T; OYAMA, T; NISHIDA, K et al.Annals of oncology. 1995, Vol 6, pp 9-13, issn 0923-7534, SUP3Conference Paper

K-ras genotypes and prognosis in non-small-cell lung cancerROSELL, R; MONZO, M; MOLINA, F et al.Annals of oncology. 1995, Vol 6, pp 15-20, issn 0923-7534, SUP3Conference Paper